UN panel, Cavendish, and other panels don't amount to much. Anything can happen but Amarantus has no track record, none at all, of gaining anything that helped its business by being on these panels. I recall reading many quotes from Gerald of what KOLs told him about Lympro etc and that amounted to nothing. And I just read a tweet that might explain why the Dx division is the bust that it is. Sad if true
(1)
(5)
Amarantus Bioscience Holdings (AMBS) Stock Research Links